| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Chief Operating Officer | Ordinary Shares | 84.1K | $1.53M | $18.19 | Mar 4, 2025 | Direct |
| NovoCure Ltd | Chief Operating Officer | Stock Options (Right to buy) | 81.5K | $1.48M | $18.19 | Mar 4, 2025 | Direct |
| NovoCure Ltd | Chief Operating Officer | Stock Option (Right to Buy) | 45.6K | $757K | $16.59 | Nov 4, 2024 | Direct |
| NovoCure Ltd | Chief Operating Officer | Restricted Share Units | 15.3K | Oct 1, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | Mar 4, 2025 | 2 | $2.48M | 4 | Mar 6, 2025 | Chief Operating Officer |
| NVCR | NovoCure Ltd | Mar 3, 2025 | 1 | -$4.63K | 4 | Mar 4, 2025 | Chief Operating Officer |
| NVCR | NovoCure Ltd | Feb 27, 2025 | 3 | -$39.7K | 4/A | Mar 3, 2025 | Chief Operating Officer |
| NVCR | NovoCure Ltd | Jan 11, 2025 | 1 | -$57.9K | 4 | Jan 15, 2025 | Chief Operating Officer |
| NVCR | NovoCure Ltd | Nov 2, 2024 | 3 | $756K | 4 | Nov 6, 2024 | Chief Operating Officer |
| NVCR | NovoCure Ltd | Nov 1, 2024 | 1 | -$2.54K | 4 | Nov 4, 2024 | Chief Operating Officer |
| NVCR | NovoCure Ltd | Oct 1, 2024 | 0 | $0 | 3 | Oct 9, 2024 | Chief Operating Officer |